2011;42:3087 3092. doi: 10.1161/ STROKEAHA.111.623165. 196. Nikaina I, Paterakis K, Paraforos G, Dardiotis E, ChovasA, Papadopoulos D, Brotis A, Komnos A. Cerebral perfusion pressure, microdialy- sis biochemistry, and clinical outcome in patients with spontaneous intracerebral hematomas. J Crit Care. 2012;27:83 88. doi: 10.1016/j. jcrc.2011.04.004. 197. Wolfe TJ, Torbey MT. Management of intracranial pressure. Curr Neurol Neurosci Rep. 2009;9:477 485. 198. Kamel H, Navi BB, Nakagawa K, Hemphill JC 3rd, Ko NU. Hypertonic saline versus mannitol for the treatment of elevated intracranial pres- sure: a meta-analysis of randomized clinical trials. Crit Care Med. 2011;39:554 559. doi: 10.1097/CCM.0b013e318206b9be. 199. Poungvarin N, Bhoopat W, Viriyavejakul A, Rodprasert P, Buranasiri P, Sukondhabhant S, Hensley MJ, Strom BL. Effects of dexametha- sone in primary supratentorial intracerebral hemorrhage. N Engl J Med. 1987;316:1229 1233. doi: 10.1056/NEJM198705143162001. 200. Hemphill JC 3rd, Morabito D, Farrant M, Manley GT. Brain tis- sue oxygen monitoring in intracerebral hemorrhage. Neurocrit Care. 2005;3:260 270. doi: 10.1385/NCC:3:3:260. 201. Miller CM, Vespa PM, McArthur DL, Hirt D, Etchepare M. Frameless stereotactic aspiration and thrombolysis of deep intracerebral hemor- rhage is associated with reduced levels of extracellular cerebral glutamate and unchanged lactate pyruvate ratios. Neurocrit Care. 2007;6:22 29. doi: 10.1385/NCC:6:1:22. 202. Hallevi H, Albright KC, Aronowski J, Barreto AD, Martin-Schild S, Khaja AM, Gonzales NR, Illoh K, Noser EA, Grotta JC. Intraventricular hemorrhage: anatomic relationships and clinical implications. Neurology. 2008;70:848 852. doi: 10.1212/01.wnl.0000304930.47751.75. 203. Huttner HB, Hartmann M, K hrmann M, Neher M, Stippich C, H hnel S, Kress B. Repeated digital substraction angiography after perimesencephalic subarachnoid hemorrhage? J Neuroradiol. 2006;33:87 89. 204. Gaberel T, Magheru C, Emery E. Management of non-traumatic intra- ventricular hemorrhage. Neurosurg Rev. 2012;35:485 494. doi: 10.1007/ s10143-012-0399-9. 205. Engelhard HH, Andrews CO, Slavin KV, Charbel FT. Current manage- ment of intraventricular hemorrhage. Surg Neurol. 2003;60:15 21. 206. Casta o vila S, Corral Lozano E, Vallejo De La Cueva A, Maynar Moliner J, Mart n L pez A, Fonseca San Miguel F, Urturi Matos JA, Manzano Ram rez A. Intraventricular hemorrhage treated with intraven- tricular fibrinolysis: a 10-year experience. Med Intensiva. 2013;37:61 66. doi: 10.1016/j.medin.2012.02.011. 207. Dunatov S, Antoncic I, Bralic M, Jurjevic A. Intraventricular thromboly- sis with rt-PA in patients with intraventricular hemorrhage. Acta Neurol Scand. 2011;124:343 348. doi: 10.1111/j.1600-0404.2010.01481.x. 208. Fountas KN, Kapsalaki EZ, Parish DC, Smith B, Smisson HF, Johnston KW, Robinson JS. Intraventricular administration of rt-PA in patients with intraventricular hemorrhage. South Med J. 2005;98:767 773. doi: 10.1097/01.smj.0000170732.24324.ea. 209. Gaberel T, Magheru C, Parienti JJ, Huttner HB, Vivien D, Emery E. Intraventricular fibrinolysis versus external ventricular drainage alone in intraventricular hemorrhage: a meta-analysis. Stroke. 2011;42:2776 2781. doi: 10.1161/STROKEAHA.111.615724. 210. Lapointe M, Haines S. Fibrinolytic therapy for intraventricular hemor- rhage in adults. Cochrane Database Syst Rev. 2002;(3):CD003692. 211. Naff NJ, Hanley DF, Keyl PM, Tuhrim S, Kraut M, Bederson J, Bullock R, Mayer SA, Schmutzhard E. Intraventricular thrombolysis speeds blood clot resolution: results of a pilot, prospective, randomized, double- blind, controlled trial. Neurosurgery. 2004;54:577 583. 212. Nieuwkamp DJ, de Gans K, Rinkel GJ, Algra A. Treatment and outcome of severe intraventricular extension in patients with subarachnoid or intracerebral hemorrhage: a systematic review of the literature. J Neurol. 2000;247:117 121. 213. Pang D, Sclabassi RJ, Horton JA. Lysis of intraventricular blood clot with urokinase in a canine model: part 3. effects of intraventricular uro- kinase on clot lysis and posthemorrhagic hydrocephalus. Neurosurgery. 1986;19:553 572. 214. King NK, Lai JL, Tan LB, Lee KK, Pang BC, Ng I, Wang E. A ran- domized, placebo-controlled pilot study of patients with spontaneous intraventricular haemorrhage treated with intraventricular thrombolysis. J Clin Neurosci. 2012;19:961 964. doi: 10.1016/j.jocn.2011.09.030. 215. Staykov D, Huttner HB, Struffert T, Ganslandt O, Doerfler A, Schwab S, Bardutzky J. Intraventricular fibrinolysis and lumbar drainage for ventricular hemorrhage. Stroke. 2009;40:3275 3280. doi: 10.1161/ STROKEAHA.109.551945. 216. Staykov D, Wagner I, Volbers B, Huttner HB, Doerfler A, Schwab S, Bardutzky J. Dose effect of intraventricular fibrinolysis in ven- tricular hemorrhage. Stroke. 2011;42:2061 2064. doi: 10.1161/ STROKEAHA.110.608190. 217. Morgan T, Awad I, Keyl P, Lane K, Hanley D. Preliminary report of the clot lysis evaluating accelerated resolution of intraventricular hemorrhage (CLEAR-IVH) clinical trial. Acta Neurochir Suppl. 2008;105:217 220. 218. Naff N, Williams MA, Keyl PM, Tuhrim S, Bullock MR, Mayer SA, Coplin W, Narayan R, Haines S, Cruz-Flores S, Zuccarello M, Brock D, Awad I, Ziai WC, Marmarou A, Rhoney D, McBee N, Lane K, Hanley DF Jr. Low-dose recombinant tissue-type plasminogen activa- tor enhances clot resolution in brain hemorrhage: the Intraventricular Hemorrhage Thrombolysis Trial. Stroke. 2011;42:3009 3016. doi: 10.1161/STROKEAHA.110.610949. 219. Webb AJ, Ullman NL, Mann S, Muschelli J, Awad IA, Hanley DF. Resolution of intraventricular hemorrhage varies by ventricular region and dose of intraventricular thrombolytic: the Clot Lysis: Evaluating Accelerated Resolution of IVH (CLEAR IVH) program. Stroke. 2012;43:1666 1668. doi: 10.1161/STROKEAHA.112.650523. 220. Basaldella L, Marton E, Fiorindi A, Scarpa B, Badreddine H, Longatti P. External ventricular drainage alone versus endoscopic surgery for severe intraventricular hemorrhage: a comparative retrospective analysis on outcome and shunt dependency. Neurosurg Focus. 2012;32:E4. doi: 10.3171/2012.1.FOCUS11349. 221. Chen CC, Liu CL, Tung YN, Lee HC, Chuang HC, Lin SZ, Cho DY. Endoscopic surgery for intraventricular hemorrhage (IVH) caused by thalamic hemorrhage: comparisons of endoscopic surgery and external ventricular drainage (EVD) surgery. World Neurosurg. 2011;75:264 268. doi: 10.1016/j.wneu.2010.07.041. 222. Yadav YR, Mukerji G, Shenoy R, Basoor A, Jain G, Nelson A. Endoscopic management of hypertensive intraventricular haemor- rhage with obstructive hydrocephalus. BMC Neurol. 2007;7:1. doi: 10.1186/1471-2377-7-1. 223. Zhang Z, Li X, Liu Y, Shao Y, Xu S, Yang Y. Application of neuroendos- copy in the treatment of intraventricular hemorrhage. Cerebrovasc Dis. 2007;24:91 96. doi: 10.1159/000103122. 224. Yilmazlar S, Abas F, Korfali E. Comparison of ventricular drain- age in poor grade patients after intracranial hemorrhage. Neurol Res. 2005;27:653 656. doi: 10.1179/016164105X35657. 225. Oertel JM, MondorfY, Baldauf J, Schroeder HW, Gaab MR. Endoscopic third ventriculostomy for obstructive hydrocephalus due to intra- cranial hemorrhage with intraventricular extension. J Neurosurg. 2009;111:1119 1126. doi: 10.3171/2009.4.JNS081149. 226. Mendelow AD, Gregson BA, Rowan EN, Murray GD, Gholkar A, Mitchell PM; STICH II Investigators. Early surgery versus initial con- servative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial [published cor- rection appears in Lancet. 2013;382:396]. Lancet. 2013;382:397 408. doi: 10.1016/S0140-6736(13)60986-1. 227. Wang WZ, Jiang B, Liu HM, Li D, Lu CZ, Zhao YD, Sander JW. Minimally invasive craniopuncture therapy vs. conservative treat- ment for spontaneous intracerebral hemorrhage: results from a ran- domized clinical trial in China. Int J Stroke. 2009;4:11 16. doi: 10.1111/j.1747-4949.2009.00239.x. 228. Prasad K, Mendelow AD, Gregson B. Surgery for primary supra- tentorial intracerebral haemorrhage. Cochrane Database Syst Rev. 2008;(4):CD000200. doi: 10.1002/14651858.CD000200.pub2. 229. Zhou X, Chen J, Li Q, Ren G, Yao G, Liu M, Dong Q, Guo J, Li L, Guo J, Xie P. Minimally invasive surgery for spontaneous supratentorial intra- cerebral hemorrhage: a meta-analysis of randomized controlled trials. Stroke. 2012;43:2923 2930. doi: 10.1161/STROKEAHA.112.667535. 230. Xiao B, Wu FF, Zhang H, Ma YB. A randomized study of urgent computed tomography-based hematoma puncture and aspiration in the emergency department and subsequent evacuation using craniec- tomy versus craniectomy only. J Neurosurg. 2012;117:566 573. doi: 10.3171/2012.5.JNS111611. 231. Mould WA, Carhuapoma JR, Muschelli J, Lane K, Morgan TC, McBee NA, Bistran-Hall AJ, Ullman NL, Vespa P, Martin NA, Awad I, Zuccarello M, Hanley DF; MISTIE Investigators. Minimally invasive surgery plus recombinant tissue-type plasminogen activator for intrace- rebral hemorrhage evacuation decreases perihematomal edema. Stroke. 2013;44:627 634. doi: 10.1161/STROKEAHA.111.000411. 232. Fung C, Murek M, Z Graggen WJ, Kr henb hl AK, Gautschi OP, Schucht P, Gralla J, Schaller K, Arnold M, Fischer U, Mattle HP, Raabe A, Beck J. Decompressive hemicraniectomy in patients with supratento- rial intracerebral hemorrhage. Stroke. 2012;43:3207 3211. doi: 10.1161/ STROKEAHA.112.666537. 233. Takeuchi S, Wada K, Nagatani K, Otani N, Mori K. Decompressive hemicraniectomy for spontaneous intracerebral hemorrhage. Neurosurg Focus. 2013;34:E5. doi: 10.3171/2013.2.FOCUS12424. 234. Heuts SG, Bruce SS, Zacharia BE, Hickman ZL, Kellner CP, Sussman ES, McDowell MM, Bruce RA, Connolly ES Jr. Decompressive hemi- craniectomy without clot evacuation in dominant-sided intracere- bral hemorrhage with ICP crisis. Neurosurg Focus. 2013;34:E4. doi: 10.3171/2013.2.FOCUS1326. 235. Mendelow AD, Gregson BA, Fernandes HM, Murray GD, Teasdale GM, Hope DT, Karimi A, Shaw MD, Barer DH; STICH investigators. Early surgery versus initial conservative treatment in patients with spontane- ous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet. 2005;365:387 397. doi: 10.1016/S0140-6736(05)17826-X. 236. Mendelow AD, Gregson BA, Mitchell PM, Murray GD, Rowan EN, Gholkar AR; STICH II Investigators. Surgical Trial in Lobar Intracerebral Haemorrhage (STICH II) protocol. Trials. 2011;12:124. doi: 10.1186/1745-6215-12-124. 237. Da Pian R, Bazzan A, Pasqualin A. Surgical versus medical treatment of spontaneous posterior fossa haematomas: a cooperative study on 205 cases. Neurol Res. 1984;6:145 151. 238. Firsching R, Huber M, Frowein RA. Cerebellar haemorrhage: manage- ment and prognosis. Neurosurg Rev. 1991;14:191 194. 239. van Loon J, Van Calenbergh F, Goffin J, Plets C. Controversies in the management of spontaneous cerebellar haemorrhage: a consecutive series of 49 cases and review of the literature. Acta Neurochir (Wien). 1993;122:187 193. 240. Hayes SB, Benveniste RJ, Morcos JJ, Aziz-Sultan MA, Elhammady MS. Retrospective comparison of craniotomy and decompres- sive craniectomy for surgical evacuation of nontraumatic, supratentorial intracerebral hemorrhage. Neurosurg Focus. 2013;34:E3. doi: 10.3171/2013.2.FOCUS12422. 241. Morgan T, Zuccarello M, Narayan R, Keyl P, Lane K, Hanley D. Preliminary findings of the minimally-invasive surgery plus rtPA for intracerebral hemorrhage evacuation (MISTIE) clinical trial. Acta Neurochir Suppl. 2008;105:147 151. 242. Auer LM, Deinsberger W, Niederkorn K, Gell G, Kleinert R, Schneider G, Holzer P, Bone G, Mokry M, K rner E, Kleinert G, Hanusch S. Endoscopic surgery versus medical treatment for spontaneous intrace- rebral hematoma: a randomized study. J Neurosurg. 1989;70:530 535. doi: 10.3171/jns.1989.70.4.0530. 243. Cho DY, Chen CC, Chang CS, Lee WY, Tso M. Endoscopic surgery for spontaneous basal ganglia hemorrhage: comparing endoscopic surgery, stereotactic aspiration, and craniotomy in noncomatose patients. Surg Neurol. 2006;65:547 555. 244. Gregson BA, Rowan EN, Mendelow AD. Letter to the editor by Gregson et al regarding article, Minimally Invasive Surgery for Spontaneous Supratentorial Intracerebral Hemorrhage: A Meta-Analysis of Randomized Controlled Trials. Stroke. 2013;44:e45. doi: 10.1161/ STROKEAHA.111.000296. 245. Zuccarello M, Brott T, Derex L, Kothari R, Sauerbeck L, Tew J, Van Loveren H,Yeh HS, Tomsick T, Pancioli A, Khoury J, Broderick J. Early surgical treatment for supratentorial intracerebral hemorrhage: a ran- domized feasibility study. Stroke. 1999;30:1833 1839. 246. Pantazis G, Tsitsopoulos P, Mihas C, Katsiva V, Stavrianos V, Zymaris S. Early surgical treatment vs conservative management for spontaneous supratentorial intracerebral hematomas: a prospective randomized study. Surg Neurol. 2006;66:492 501. 247. Gregson BA, Broderick JP, Auer LM, Batjer H, Chen XC, Juvela S, Morgenstern LB, Pantazis GC, Teernstra OP, Wang WZ, Zuccarello M, Mendelow AD. Individual patient data subgroup meta-analysis of sur- gery for spontaneous supratentorial intracerebral hemorrhage [published correction appears in Stroke. 2013;44:e82]. Stroke. 2012;43:1496 1504. doi: 10.1161/STROKEAHA.111.640284. 248. Morgenstern LB, Demchuk AM, Kim DH, Frankowski RF, Grotta JC. Rebleeding leads to poor outcome in ultra-early craniotomy for intrace- rebral hemorrhage. Neurology. 2001;56:1294 1299. 249. Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G. Volume of intracerebral hemorrhage: a powerful and easy-to-use predictor of 30-day mortality. Stroke. 1993;24:987 993. 250. Ariesen MJ, Algra A, van der Worp HB, Rinkel GJ. Applicability and relevance of models that predict short term outcome after intracerebral haemorrhage. J Neurol Neurosurg Psychiatry. 2005;76:839 844. doi: 10.1136/jnnp.2004.048223. 251. Cheung RT, Zou LY. Use of the original, modified, or new intracere- bral hemorrhage score to predict mortality and morbidity after intra- cerebral hemorrhage. Stroke. 2003;34:1717 1722. doi: 10.1161/01. STR.0000078657.22835.B9. 252. Lisk DR, Pasteur W, Rhoades H, Putnam RD, Grotta JC. Early presenta- tion of hemispheric intracerebral hemorrhage: prediction of outcome and guidelines for treatment allocation. Neurology. 1994;44:133 139. 253. Ruiz-Sandoval JL, Chiquete E, Romero-Vargas S, Padilla-Mart nez JJ, Gonz lez-Cornejo S. Grading scale for prediction of outcome in primary intracerebral hemorrhages. Stroke. 2007;38:1641 1644. doi: 10.1161/ STROKEAHA.106.478222. 254. Tuhrim S, Dambrosia JM, Price TR, Mohr JP, Wolf PA, Hier DB, Kase CS. Intracerebral hemorrhage: external validation and extension of a model for prediction of 30-day survival. Ann Neurol. 1991;29:658 663. doi: 10.1002/ana.410290614. 255. Tuhrim S, Horowitz DR, Sacher M, Godbold JH. Validation and compar- ison of models predicting survival following intracerebral hemorrhage. Crit Care Med. 1995;23:950 954. 256. Tuhrim S, Horowitz DR, Sacher M, Godbold JH. Volume of ventricular blood is an important determinant of outcome in supratentorial intracere- bral hemorrhage. Crit Care Med. 1999;27:617 621. 257. Naidech AM, Bernstein RA, Bassin SL, Garg RK, Liebling S, Bendok BR, Batjer HH, Bleck TP. How patients die after intracerebral hemor- rhage. Neurocrit Care. 2009;11:45 49. doi: 10.1007/s12028-009-9186-z. 258. Zurasky JA, Aiyagari V, Zazulia AR, Shackelford A, Diringer MN. Early mortality following spontaneous intracerebral hemorrhage. Neurology. 2005;64:725 727. doi: 10.1212/01.WNL.0000152045.56837.58. 259. Holloway RG, Arnold RM, Creutzfeldt CJ, Lewis EF, Lutz BJ, McCann RM, Rabinstein AA, Saposnik G, Sheth KN, Zahuranec DB, Zipfel GJ, Zorowitz RD; American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, and Council on Clinical Cardiology. Hemphill et al Management of Spontaneous ICH 2059 Palliative and end-of-life care in stroke: a statement for healthcare profes- sionalsfromtheAmericanHeartAssociation/AmericanStrokeAssociation. Stroke. 2014;45:1887 1916. doi: 10.1161/STR.0000000000000015. 260. Becker KJ, Baxter AB, Cohen WA, Bybee HM, Tirschwell DL, Newell DW, Winn HR, Longstreth WT Jr. Withdrawal of support in intrace- rebral hemorrhage may lead to self-fulfilling prophecies. Neurology. 2001;56:766 772. 261. Hemphill JC 3rd, Newman J, Zhao S, Johnston SC. Hospital usage of early do-not-resuscitate orders and outcome after intracerebral hemor- rhage. Stroke. 2004;35:1130 1134. doi: 10.1161/01.STR.0000125858. 71051.ca. 262. Zahuranec DB, Brown DL, Lisabeth LD, Gonzales NR, Longwell PJ, Smith MA, Garcia NM, Morgenstern LB. Early care limitations inde- pendently predict mortality after intracerebral hemorrhage. Neurology. 2007;68:1651 1657. doi: 10.1212/01.wnl.0000261906.93238.72. 263. Mirski MA, Chang CW, Cowan R. Impact of a neuroscience intensive care unit on neurosurgical patient outcomes and cost of care: evidence- based support for an intensivist-directed specialty ICU model of care. J Neurosurg Anesthesiol. 2001;13:83 92. 264. Creutzfeldt CJ, Becker KJ, Weinstein JR, Khot SP, McPharlin TO, Ton TG, Longstreth WT Jr, Tirschwell DL. Do-not-attempt-resuscitation orders and prognostic models for intraparenchymal hemorrhage. Crit Care Med. 2011;39:158 162. doi: 10.1097/CCM.0b013e3181fb7b49. 265. Zahuranec DB, Morgenstern LB, S nchez BN, Resnicow K, White DB, Hemphill JC 3rd. Do-not-resuscitate orders and predictive models after intracerebral hemorrhage. Neurology. 2010;75:626 633. doi: 10.1212/ WNL.0b013e3181ed9cc9. 266. Hemphill JC 3rd, White DB. Clinical nihilism in neuroemergencies. Emerg Med Clin North Am. 2009;27:27 37, vii viii. doi: 10.1016/j. emc.2008.08.009. 267. Arima H, Tzourio C, Butcher K, Anderson C, Bousser MG, Lees KR, Reid JL, Omae T, Woodward M, MacMahon S, Chalmers J; PROGRESS Collaborative Group. Prior events predict cerebrovascular and coronary outcomes in the PROGRESS trial. Stroke. 2006;37:1497 1502. doi: 10.1161/01.STR.0000221212.36860.c9. 268. Vermeer SE, Algra A, Franke CL, Koudstaal PJ, Rinkel GJ. Long- term prognosis after recovery from primary intracerebral hemorrhage. Neurology. 2002;59:205 209. 269. Hanger HC, Wilkinson TJ, Fayez-Iskander N, Sainsbury R. The risk of recurrent stroke after intracerebral haemorrhage. J Neurol Neurosurg Psychiatry. 2007;78:836 840. doi: 10.1136/jnnp.2006.106500. 270. Weimar C, Benemann J, Terborg C, Walter U, Weber R, Diener HC; German Stroke Study Collaboration. Recurrent stroke after lobar and deep intracerebral hemorrhage: a hospital-based cohort study. Cerebrovasc Dis. 2011;32:283 288. doi: 10.1159/000330643. 271. Izumihara A, Suzuki M, Ishihara T. Recurrence and extension of lobar hemorrhage related to cerebral amyloid angiopathy: multivariate analy- sis of clinical risk factors. Surg Neurol. 2005;64:160 164. 272. Biffi A, Halpin A, Towfighi A, Gilson A, Busl K, Rost N, Smith EE, Greenberg MS, Rosand J, Viswanathan A. Aspirin and recurrent intra- cerebral hemorrhage in cerebral amyloid angiopathy. Neurology. 2010;75:693 698. doi: 10.1212/WNL.0b013e3181eee40f. 273. Tzourio C, Arima H, Harrap S, Anderson C, Godin O, Woodward M, Neal B, Bousser MG, Chalmers J, Cambien F, MacMahon S. APOE genotype, ethnicity, and the risk of cerebral hemorrhage. Neurology. 2008;70:1322 1328. doi: 10.1212/01.wnl.0000308819.43401.87. 274. O Donnell HC, Rosand J, Knudsen KA, Furie KL, Segal AZ, Chiu RI, Ikeda D, Greenberg SM. Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N Engl J Med. 2000;342:240 245. doi: 10.1056/NEJM200001273420403. 275. Greenberg SM, Eng JA, Ning M, Smith EE, Rosand J. Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage. Stroke. 2004;35:1415 1420. doi: 10.1161/01.STR.0000126807.69758.0e. 276. Inagawa T. Recurrent primary intracerebral hemorrhage in Izumo City, Japan. Surg Neurol. 2005;64:28 35. 277. Huhtakangas J, L pp nen P, Tetri S, Juvela S, Saloheimo P, Bode MK, Hillbom M. Predictors for recurrent primary intracerebral hemorrhage: a retrospective population-based study. Stroke. 2013;44:585 590. doi: 10.1161/STROKEAHA.112.671230. 278. Azarpazhooh MR, Nicol MB, Donnan GA, Dewey HM, Sturm JW, Macdonell RA, Pearce DC, Thrift AG. Patterns of stroke recurrence according to subtype of first stroke event: the North East Melbourne Stroke Incidence Study (NEMESIS). Int J Stroke. 2008;3:158 164. doi: 10.1111/j.1747-4949.2008.00204.x. 279. PROGRESS Collaborative Group. Randomised trial of a perindopril- based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack [published corrections appear in Lancet. 2002;359:2120 and Lancet. 2001;358:1556]. Lancet. 2001;358:1033 1041. 280. Arima H, Chalmers J, Woodward M, Anderson C, Rodgers A, Davis S, Macmahon S, Neal B; PROGRESS Collaborative Group. Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial. J Hypertens. 2006;24:1201 1208. doi: 10.1097/01.hjh.0000226212.34055.86. 281. White CL, Pergola PE, Szychowski JM, Talbert R, Cervantes-Arriaga A, Clark HD, Del Brutto OH, Godoy IE, Hill MD, Pelegr A, Sussman CR, Taylor AA, Valdivia J, Anderson DC, Conwit R, Benavente OR; SPS3 Investigators. Blood pressure after recent stroke: baseline findings from the secondary prevention of small subcortical strokes trial. Am J Hypertens. 2013;26:1114 1122. doi: 10.1093/ajh/hpt076. 282. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report [published correction appears in JAMA. 2003;290:197]. JAMA. 2003;289:2560 2572. doi: 10.1001/jama.289.19.2560. 283. Pontes-Neto OM, Fernandes RM, Sander HH, da Silva LA, Mariano DC, Nobre F, Sim o G, de Araujo DB, dos Santos AC, Leite JP. Obstructive sleep apnea is frequent in patients with hypertensive intracerebral hemorrhage and is related to perihematoma edema. Cerebrovasc Dis. 2010;29:36 42. doi: 10.1159/000255972. 284. Khan A, Patel NK, O Hearn DJ, Khan S. Resistant hypertension and obstructive sleep apnea. Int J Hypertens. 2013;2013:193010. doi: 10.1155/2013/193010. 285. Woo D, Sauerbeck LR, Kissela BM, Khoury JC, Szaflarski JP, Gebel J, Shukla R, Pancioli AM, Jauch EC, Menon AG, Deka R, Carrozzella JA, Moomaw CJ, Fontaine RN, Broderick JP. Genetic and environmen- tal risk factors for intracerebral hemorrhage: preliminary results of a population-based study. Stroke. 2002;33:1190 1195. DOI: 10.1161/01. STR.0000014774.88027.22. 286. Gee P, Tallon C, Long N, Moore G, Boet R, Jackson S. Use of recre- ational drug 1,3 Dimethylamylamine (DMAA) [corrected] associated with cerebral hemorrhage [published correction appears in Ann Emerg Med. 2013;61:26]. Ann Emerg Med. 2012;60:431 434. doi: 10.1016/j. annemergmed.2012.04.008. 287. Ariesen MJ, Claus SP, Rinkel GJ, Algra A. Risk factors for intracere- bral hemorrhage in the general population: a systematic review. Stroke. 2003;34:2060 2065. doi: 10.1161/01.STR.0000080678.09344.8D. 288. Kurth T, Kase CS, Berger K, Gaziano JM, Cook NR, Buring JE. Smoking and risk of hemorrhagic stroke in women. Stroke. 2003;34:2792 2795. doi: 10.1161/01.STR.0000100165.36466.95. 289. Kurth T, Kase CS, Berger K, Schaeffner ES, Buring JE, Gaziano JM. Smoking and the risk of hemorrhagic stroke in men. Stroke. 2003;34:1151 1155. doi: 10.1161/01.STR.0000065200.93070.32. 290. O Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, Rangarajan S, Islam S, Pais P, McQueen MJ, Mondo C, Damasceno A, Lopez-Jaramillo P, Hankey GJ, Dans AL, Yusoff K, Truelsen T, Diener HC, Sacco RL, Ryglewicz D, Czlonkowska A, Weimar C, Wang X, Yusuf S; INTERSTROKE investigators. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet. 2010;376:112 123. doi: 10.1016/ S0140-6736(10)60834-3. factors on the risks of ischemic and hemorrhagic stroke. Arch Intern Med. 2011;171:1811 1818. doi: 10.1001/archinternmed.2011.443. 292. Kennedy BS, Kasl SV, Lichtman J, Zhao H. Predicting readmis- sion stroke type among blacks and whites in California. J Stroke Cerebrovasc Dis. 2005;14:251 260. doi: 10.1016/j.jstrokecerebrovasdis. 2005.08.003. 293. Yung D, Kapral MK, Asllani E, Fang J, Lee DS; Investigators of the Registry of the Canadian Stroke Network. Reinitiation of anticoagula- tion after warfarin-associated intracranial hemorrhage and mortality risk: the Best Practice for Reinitiating Anticoagulation Therapy After Intracranial Bleeding (BRAIN) study. Can J Cardiol. 2012;28:33 39. doi: 10.1016/j.cjca.2011.10.002. 294. Majeed A, Kim YK, Roberts RS, Holmstr m M, Schulman S. Optimal timing of resumption of warfarin after intracranial hemorrhage. Stroke. 2010;41:2860 2866. doi: 10.1161/STROKEAHA.110.593087. anticoagulation therapy after warfarin-associated intracerebral hemorrhage. Arch Neurol. 2008;65:1313 1318. doi: 10.1001/archneur.65.10.1313. be anticoagulated after intracerebral hemorrhage? A decision analysis. Stroke. 2003;34:1710 1716. doi: 10.1161/01.STR.0000078311.18928.16. 297. Lovelock CE, Cordonnier C, Naka H, Al-Shahi Salman R, Sudlow CL, Sorimachi T, Werring DJ, Gregoire SM, Imaizumi T, Lee SH, Briley D, Rothwell PM; Edinburgh Stroke Study Group. Antithrombotic drug use, cerebral microbleeds, and intracerebral hemorrhage: a systematic review of published and unpublished studies. Stroke. 2010;41:1222 1228. doi: 10.1161/STROKEAHA.109.572594. 298. Ananthasubramaniam K, Beattie JN, Rosman HS, Jayam V, Borzak S. How safely and for how long can warfarin therapy be withheld in pros- thetic heart valve patients hospitalized with a major hemorrhage? Chest. 2001;119:478 484. 299. Butler AC, Tait RC. Restarting anticoagulation in prosthetic heart valve patients after intracranial haemorrhage: a 2-year follow-up. Br J Haematol. 1998;103:1064 1066. 300. Phan TG, Koh M, Wijdicks EF. Safety of discontinuation of anticoagu- lation in patients with intracranial hemorrhage at high thromboembolic risk. Arch Neurol. 2000;57:1710 1713. 301. Flynn RW, MacDonald TM, Murray GD, MacWalter RS, Doney AS. Prescribing antiplatelet medicine and subsequent events after intra- cerebral hemorrhage. Stroke. 2010;41:2606 2611. doi: 10.1161/ STROKEAHA.110.589143. 302. Connolly SJ, Pogue J, Hart RG, Hohnloser SH, Pfeffer M, Chrolavicius S,Yusuf S; ACTIVE Investigators. Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med. 2009;360:2066 2078. doi: 10.1056/NEJMoa0901301. 303. Reddy VY, Doshi SK, Sievert H, Buchbinder M, Neuzil P, Huber K, Halperin JL, Holmes D; PROTECT AF Investigators. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial. Circulation. 2013;127:720 729. doi: 10.1161/ CIRCULATIONAHA.112.114389. 304. Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FW, Zhu J, Wallentin L; ARISTOTLE Committees and Investigators. Apixaban versus warfarin in patients with atrial fibrilla- tion. N Engl J Med. 2011;365:981 992. doi: 10.1056/NEJMoa1107039. 305. He J, Whelton PK, Vu B, Klag MJ. Aspirin and risk of hemor- rhagic stroke: a meta-analysis of randomized controlled trials. JAMA. 1998;280:1930 1935. 306. Thompson BB, B jot Y, Caso V, Castillo J, Christensen H, Flaherty ML, Foerch C, Ghandehari K, Giroud M, Greenberg SM, Hallevi H, Hemphill JC 3rd, Heuschmann P, Juvela S, Kimura K, Myint PK, Nagakane Y, Naritomi H, Passero S, Rodr guez-Y ez MR, Roquer J, Rosand J, Rost NS, Saloheimo P, SalomaaV, Sivenius J, Sorimachi T, Togha M, Toyoda K, Turaj W,Vemmos KN, Wolfe CD, Woo D, Smith EE. Prior antiplatelet ther- apy and outcome following intracerebral hemorrhage: a systematic review. Neurology. 2010;75:1333 1342. doi: 10.1212/WNL.0b013e3181f735e5. 307. ViswanathanA, Rakich SM, Engel C, Snider R, Rosand J, Greenberg SM, Smith EE. Antiplatelet use after intracerebral hemorrhage. Neurology. 2006;66:206 209. doi: 10.1212/01.wnl.0000194267.09060.77. 308. Goldstein LB, Amarenco P, Szarek M, Callahan A 3rd, Hennerici M, Sillesen H, Zivin JA, Welch KM; SPARCL Investigators. Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study. Neurology. 2008;70(24 Pt 2):2364 2370. doi: 10.1212/01. wnl.0000296277.63350.77. 309. Hackam DG,Austin PC, HuangA, Juurlink DN, Mamdani MM, Paterson JM, Hachinski V, Li P, Kapral MK. Statins and intracerebral hemorrhage: a retrospective cohort study. Arch Neurol. 2012;69:39 45. doi: 10.1001/ archneurol.2011.228. 310. McKinney JS, Kostis WJ. Statin therapy and the risk of intracerebral hemorrhage: a meta-analysis of 31 randomized controlled trials. Stroke. 2012;43:2149 2156. doi: 10.1161/STROKEAHA.112.655894. 311. Westover MB, Bianchi MT, Eckman MH, Greenberg SM. Statin use following intracerebral hemorrhage: a decision analysis. Arch Neurol. 2011;68:573 579. doi: 10.1001/archneurol.2010.356. 312. Tapia-P rez JH, Rupa R, Zilke R, Gehring S, Voellger B, Schneider T. Continued statin therapy could improve the outcome after spontane- ous intracerebral hemorrhage. Neurosurg Rev. 2013;36:279 287. doi: 10.1007/s10143-012-0431-0. 313. Haussen DC, Henninger N, Kumar S, Selim M. Statin use and micro- bleeds in patients with spontaneous intracerebral hemorrhage. Stroke. 2012;43:2677 2681. doi: 10.1161/STROKEAHA.112.657486. 314. Chae J, Zorowitz RD, Johnston MV. Functional outcome of hemorrhagic and nonhemorrhagic stroke patients after in-patient rehabilitation. Am J Phys Med Rehabil. 1996;75:177 182. 315. Kelly PJ, Furie KL, Shafqat S, Rallis N, Chang Y, Stein J. Functional recovery following rehabilitation after hemorrhagic and ischemic stroke. Arch Phys Med Rehabil. 2003;84:968 972. 316. Schepers VP, Ketelaar M, Visser-Meily AJ, de Groot V, Twisk JW, Lindeman E. Functional recovery differs between ischaemic and haemorrhagic stroke patients. J Rehabil Med. 2008;40:487 489. doi: 10.2340/16501977-0198. 317. Katrak PH, Black D, Peeva V. Do stroke patients with intracerebral hemorrhage have a better functional outcome than patients with cerebral infarction? PM R. 2009;1:427 433. doi: 10.1016/j.pmrj.2009.03.002. 318. Jang SH. A review of diffusion tensor imaging studies on motor recovery mechanisms in stroke patients. NeuroRehabilitation. 2011;28:345 352. doi: 10.3233/NRE-2011-0662. 319. Stroke Unit Trialists Collaboration. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev. 2007;(4):CD000197. 320. Outpatient Service Trialists. Therapy-based rehabilitation services for stroke patients at home. Cochrane Database Syst Rev. 2003;(1):CD002925. 321. Chan DK, Cordato D, O Rourke F, Chan DL, Pollack M, Middleton S, Levi C. Comprehensive stroke units: a review of compara- tive evidence and experience. Int J Stroke. 2013;8:260 264. doi: 10.1111/j.1747-4949.2012.00850.x. 322. Bai Y, Hu Y, Wu Y, Zhu Y, He Q, Jiang C, Sun L, Fan W. A pro- spective, randomized, single-blinded trial on the effect of early rehabilitation on daily activities and motor function of patients with hemorrhagic stroke. J Clin Neurosci. 2012;19:1376 1379. doi: 10.1016/j.jocn.2011.10.021. 323. Cumming TB, Thrift AG, Collier JM, Churilov L, Dewey HM, Donnan GA, Bernhardt J. Very early mobilization after stroke fast- tracks return to walking: further results from the phase II AVERT randomized controlled trial. Stroke. 2011;42:153 158. doi: 10.1161/ STROKEAHA.110.594598. 324. Qureshi AI, Palesch YY. Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II: design, methods, and rationale. Neurocrit Care. 2011;15:559 576. doi: 10.1007/s12028-011-9538-3. 325. Goldstein J, Brouwers H, Romero J, McNamara K, Schwab K, Greenberg S, Rosand J. SCORE-IT: the Spot Sign score in restricting ICH growth: an ATACH-II ancillary study. J Vasc Intervent Neurol. 2012;5(suppl):20 25. 326. Tymianski M. Novel approaches to neuroprotection trials in acute isch- emic stroke. Stroke. 2013;44:2942 2950. doi: 10.1161/STROKEAHA. 113.000731. 327. Saver JL, Starkman S, Eckstein M, Stratton S, Pratt F, Hamilton S, Conwit R, Liebeskind DS, Sung G, Sanossian N; FAST-MAG Investigators and Coordinators. Methodology of the Field Administration of Stroke Therapy Magnesium (FAST-MAG) phase 3 trial: part 2: prehospital study methods. Int J Stroke. 2014;9:220 225. doi: 10.1111/ijs.12242. 328. Benavente OR, Coffey CS, Conwit R, Hart RG, McClure LA, Pearce LA, Pergola PE, Szychowski JM. Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial [published correc- tion appears in Lancet. 2013;382:506]. Lancet. 2013;382:507 515. doi: 10.1016/S0140-6736(13)60852-1.